PTK2 and glioblastoma: Inhibiting FGFR, integrin or FAK signaling depletes the L1CAM response in L1CAM-positive glioblastoma cells, suggesting an L1CAM-FGFR-integrin-FAK signaling axis is required for L1CAM driven motility and proliferation [269].